Bank of New York Mellon’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Bank of New York Mellon’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-277,096	Closed	-$659K	–	4274
2019 Q2	$659K	Sell	277,096 -123,438	-31%	-$369K	﹤0.01%	3463
2019 Q1	$1.5M	Sell	400,534 -62,977	-14%	-$236K	﹤0.01%	2934
2018 Q4	$1.66M	Sell	463,511 -172,616	-27%	-$751K	﹤0.01%	2827
2018 Q3	$3.65M	Buy	636,127 +134,676	+27%	+$770K	﹤0.01%	2545
2018 Q2	$2.51M	Sell	501,451 -380	-0.1%	-$1.96K	﹤0.01%	2733
2018 Q1	$2.58M	Sell	501,831 -34,083	-6%	-$205K	﹤0.01%	2678
2017 Q4	$3.22M	Sell	535,914 -35,725	-6%	-$215K	﹤0.01%	2575
2017 Q3	$3.17M	Buy	571,639 +26,786	+5%	+$138K	﹤0.01%	2561
2017 Q2	$2.53M	Buy	544,853 +151,849	+39%	+$678K	﹤0.01%	2712
2017 Q1	$1.95M	Sell	393,004 -127,482	-24%	-$1.23M	﹤0.01%	2870
2016 Q4	$5.78M	Sell	520,486 -3,988	-0.8%	-$37.5K	﹤0.01%	2244
2016 Q3	$4.86M	Sell	524,474 -26,876	-5%	-$225K	﹤0.01%	2250
2016 Q2	$3.5M	Sell	551,350 -67,230	-11%	-$446K	﹤0.01%	2402
2016 Q1	$4.03M	Sell	618,580 -32,151	-5%	-$207K	﹤0.01%	2290
2015 Q4	$5.28M	Sell	650,731 -119,828	-16%	-$896K	﹤0.01%	2180
2015 Q3	$5.65M	Buy	770,559 +114,680	+17%	+$1.17M	﹤0.01%	2174
2015 Q2	$6.72M	Buy	+655,879	New	+$7.25M	﹤0.01%	2179

Other funds holding FOMX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DAM

DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bank of New York Mellon's FOMX Position: Q3 2019 in Review

Bank of New York Mellon sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q3 2019, closing a stake of 277,096 shares — an estimated $659K sold.

Bank of New York Mellon first reported a position in FOMX in Q2 2015 and held it in 17 quarters. The position peaked at $6.72M in Q2 2015. 59 funds tracked by Wall St. Rank hold FOMX as of Q3 2019.

Bank of New York Mellon reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q3 2019 after selling out during the quarter.
Bank of New York Mellon sold 277,096 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q3 2019, an estimated $659K.
Bank of New York Mellon first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2015 and held it in 17 quarters.
Bank of New York Mellon's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $6.72M in Q2 2015.
59 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q3 2019.

Based on Bank of New York Mellon's 13F filing for Q3 2019, filed 7 Nov 2019.